Apoptosis and neutrophils in the regulation of Ph-positive myeloid cell proliferation and differentiation ex vivo

作者: N. I. Grineva , T. V. Akhlynina , A. M. Timofeev , L. P. Gerasimova , D. A. Schmarov

DOI: 10.1134/S0026893313040043

关键词:

摘要: Ex vivo proliferation and differentiation of Philadelphia chromosome-positive (Ph+) human myeloid cells (Ph+ cells) from chronic leukemia (CML) proceed via alternation stages cell neutrophil maturation. To regulate them, apoptosis is alternately blocked or induced with the help neutrophils expression bcr/abl, bax, bcl2. The regulation in main types Ph+ depends on (1) (2) maturation may follow two pathways. One consists alternating blockages inductions initial subsequent under as (2)-(1)-(2) has not been described yet. Neutrophil accumulation blocks apoptosis. As are depleted, again. Its block accelerates a new neutrophils, which followed by regular death induction way optimizes efficiency (P/D index) proliferation, allowing cycle to be completed. In another way, starts (1)-(2)-(1) at lower content) leads resistant decrease maximal level factor 3–8 compared alternation. A stable observed prolonged maturation, leading an blasts myelocytes elevated bcr/abl bcl2 > bax. associated CML progression lines. Cells first pathway apoptotic chronic-phase CML. cultivation individual patients was assumed provide for more exact diagnosis phase optimizing treatment.

参考文章(28)
N. I. Grineva, E. A. Duchovenskay, A. M. Timofeev, T. V. Akhlynina, L. P. Gerasimova, T. E. Manakova, T. V. Borovkova, D. A. Schmarov, N. G. Sarycheva, N. M. Naydenova, A. R. Gavrichkova, L. Y. Kolosova, T. I. Kolosheynova, L. G. Kovaleva, Gene expression upon proliferation and differentiation of hematopoietic cells with Ph chromosome ex vivo Acta Naturae. ,vol. 4, pp. 95- 114 ,(2012) , 10.32607/20758251-2012-4-3-95-114
A Bedi, JP Barber, GC Bedi, WS el-Deiry, D Sidransky, MS Vala, AJ Akhtar, J Hilton, RJ Jones, BCR-ABL-mediated inhibition of apoptosis with delay of G2/M transition after DNA damage: a mechanism of resistance to multiple anticancer agents Blood. ,vol. 86, pp. 1148- 1158 ,(1995) , 10.1182/BLOOD.V86.3.1148.1148
Dan A. Liebermann, Maryla Krajewska, Stanislaw Krajewski, Hong Gang Wang, Barbara Hoffman, John C. Reed, H. K. Lin, Toshiyuki Miyashita, Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo Oncogene. ,vol. 9, pp. 1799- 1805 ,(1994)
Christie M. Traycoff, Bartley Halstead, Susan Rice, Jon Mcmahel, Edward F. Srour, Kenneth Cornetta, Chronic myelogenous leukaemia CD34+ cells exit G0/G1 phases of cell cycle more rapidly than normal marrow CD34+ cells British Journal of Haematology. ,vol. 102, pp. 759- 767 ,(1998) , 10.1046/J.1365-2141.1998.00839.X
Anne-Marie Buckle, Rachel Mottram, Andrew Pierce, Guy S. Lucas, Nigel Russell, Jaleel A. Miyan, Anthony D. Whetton, The Effect of Bcr-Abl Protein Tyrosine Kinase on Maturation and Proliferation of Primitive Haematopoietic Cells Molecular Medicine. ,vol. 6, pp. 892- 902 ,(2000) , 10.1007/BF03401826
Carmine Selleri, Jaroslaw P. Maciejewski, Fabrizio Pane, Luigia Luciano, Anna Maria Raiola, Ilaria Mostarda, Francesco Salvatore, Bruno Rotoli, Fas-Mediated Modulation of Bcr/Abl in Chronic Myelogenous Leukemia Results in Differential Effects on Apoptosis Blood. ,vol. 92, pp. 981- 989 ,(1998) , 10.1182/BLOOD.V92.3.981.415K03_981_989
Niels Borregaard, Jack B. Cowland, Granules of the Human Neutrophilic Polymorphonuclear Leukocyte Blood. ,vol. 89, pp. 3503- 3521 ,(1997) , 10.1182/BLOOD.V89.10.3503
TL Holyoake, X Jiang, MW Drummond, AC Eaves, CJ Eaves, Elucidating critical mechanisms of deregulated stem cell turnover in the chronic phase of chronic myeloid leukemia Leukemia. ,vol. 16, pp. 549- 558 ,(2002) , 10.1038/SJ.LEU.2402444
Douglas R Green, Guido Kroemer, The Pathophysiology of Mitochondrial Cell Death Science. ,vol. 305, pp. 626- 629 ,(2004) , 10.1126/SCIENCE.1099320
J. M. Adams, Ways of dying: multiple pathways to apoptosis Genes & Development. ,vol. 17, pp. 2481- 2495 ,(2003) , 10.1101/GAD.1126903